Patrick O'Brien Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 1 day ago
Patrick O'Brien has an estimated net worth of at least $14.6 million*, as of Dec. 18, 2024. They own 464,385 shares of ARWR stock. They have sold 98,190 shares of ARWR stock since 2021, for an estimated $4.4 million.
Patrick O'Brien $ARWR SEC Form 4 Insider Trading
Patrick O'Brien has filed a total of 23 insider trades in $ARWR since 2021. Their most recent trade was a sale of 12,741 shares, made on Jan 05, 2024. Their largest trade was a sale of 12,741 shares, made on Jan 05, 2024. We estimate that they now own 464,385 shares of $ARWR, worth an estimated $10.3 million.
Insider Trading at $ARWR
There have been a total of 146 insider trades reported at $ARWR since 2021, with 3,655 shares purchased and 1.1 million shares sold. The most active insider traders in $ARWR stock have been Christopher Richard Anzalone, Patrick O'Brien, and Kenneth Allen Myszkowski. The most recent trade was a sale of 12,563 shares reported by Christopher Richard Anzalone (Chief Executive Officer), made on Dec 23, 2024.
History of Insider Stock Trades by Patrick O'Brien
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ARWR
|
Sale | 12,741 | Jan 05, 2024 | Jan. 5, 2024, 8:58 p.m. |
|
ARWR
|
Sale | 1,700 | Jan 03, 2024 | Jan. 5, 2024, 8:58 p.m. |
|
ARWR
|
Sale | 1,900 | Jan 05, 2024 | Jan. 5, 2024, 8:58 p.m. |
|
ARWR
|
Sale | 1,600 | Jan 04, 2024 | Jan. 5, 2024, 8:58 p.m. |
|
ARWR
|
Sale | 8,200 | Jan 05, 2024 | Jan. 5, 2024, 8:58 p.m. |
|
ARWR
|
Sale | 3,849 | Jan 03, 2024 | Jan. 5, 2024, 8:58 p.m. |
|
ARWR
|
Sale | 2,800 | Jan 03, 2024 | Jan. 5, 2024, 8:58 p.m. |
|
ARWR
|
Sale | 400 | Jan 03, 2024 | Jan. 5, 2024, 8:58 p.m. |
|
ARWR
|
Sale | 7,500 | Jan 05, 2023 | Jan. 6, 2023, 8:30 p.m. |
|
ARWR
|
Sale | 7,500 | Jan 05, 2023 | Jan. 6, 2023, 8:30 p.m. |
|
ARWR
|
Sale | 300 | Jan 03, 2023 | Jan. 5, 2023, 8:10 p.m. |
|
ARWR
|
Sale | 2,653 | Jan 03, 2023 | Jan. 5, 2023, 8:10 p.m. |
|
ARWR
|
Sale | 5,527 | Jan 03, 2023 | Jan. 5, 2023, 8:10 p.m. |
|
ARWR
|
Sale | 500 | Jan 03, 2023 | Jan. 5, 2023, 8:10 p.m. |
|
ARWR
|
Sale | 70 | Jan 03, 2023 | Jan. 5, 2023, 8:10 p.m. |
|
ARWR
|
Sale | 2,894 | Jan 03, 2023 | Jan. 5, 2023, 8:10 p.m. |
|
ARWR
|
Sale | 5,286 | Jan 03, 2023 | Jan. 5, 2023, 8:10 p.m. |
|
ARWR
|
Sale | 270 | Jan 03, 2023 | Jan. 5, 2023, 8:10 p.m. |
|
ARWR
|
Sale | 12,434 | Jan 05, 2022 | Jan. 6, 2022, 8 p.m. |
|
ARWR
|
Sale | 316 | Jan 05, 2022 | Jan. 6, 2022, 8 p.m. |
|
ARWR
|
Sale | 4,400 | Jan 05, 2022 | Jan. 6, 2022, 8 p.m. |
|
ARWR
|
Sale | 5,000 | Jan 05, 2022 | Jan. 6, 2022, 8 p.m. |
|
ARWR
|
Sale | 10,350 | Jan 05, 2022 | Jan. 6, 2022, 8 p.m. |
$ARWR Executives and Stock Owners with Insider Trades
-
Christopher Richard Anzalone, Chief Executive Officer
-
Patrick O'Brien, COO and General Counsel
-
Kenneth Allen Myszkowski, Chief Financial Officer
-
Martin Javier San, Chief Medical Officer
-
Patrick O'Brien, General Counsel
-
James C Hamilton, Chief Discovery/Trans Medicine
-
Tracie Oliver, Chief Commercial Officer
-
James Hassard, Chief Commercial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.